News
A federal panel of medical experts on Wednesday recommended an expansion of respiratory syncytial virus (RSV) vaccinations ...
9h
Pharmaceutical Technology on MSNACIP recommends GSK’s RSV vaccine for at-risk adults 50 to 59The recommendation builds on the committee’s June 2024 vote for the use of RSV vaccines for people aged 60 to 74 at high risk ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
THURSDAY, April 17, 2025 (HealthDay News) — A panel of federal health experts on Wednesday recommended expanded vaccine ...
The CDC’s Advisory Committee on Immunization Practices voted April 16 to expand use of respiratory syncytial virus vaccines among high-risk adults. The updated recommendation calls for a single ...
21hon MSN
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee ...
Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...
19h
MedPage Today on MSNACIP Endorses RSV Vaccine for At-Risk Adults 50 and UpThe CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results